Literature DB >> 4155653

Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C.

S H Ferreira, B B Vargaftig.   

Abstract

1 A crude and a partially purified preparation of slow reacting substance C (SRS-C) as well as arachidonic acid decreased resistance to perfusion of the dog hind paw. This effect was suppressed by treatment with non-steroid anti-inflammatory drugs.2 Injections of SRS-C or of arachidonic acid induced marked and reproducible contractions of strips of rabbit aorta and a rat stomach which were bathed in blood from an anaesthetized dog. The effect on the rabbit aorta is attributed to formation of a rabbit aorta contracting substance (RCS). The contractions were suppressed when the dog was treated with a non-steroid anti-inflammatory drug.3 Incubation of blood or of platelet-rich plasma with SRS-C or arachidonic acid resulted in the formation of similar materials. This formation was suppressed by anti-inflammatory drugs.4 SRS-C, linoleic, linolenic, and arachidonic acids are suitable substrates for soybean lipoxidase for the generation of RCS.5 It is suggested that RCS and prostaglandin are formed within platelets, when SRS-C or arachidonic acid are injected into animals or added in vitro. Non-steroid anti-inflammatory drugs suppress these effects, possibly by inhibiting prostaglandin synthetase.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155653      PMCID: PMC1776726          DOI: 10.1111/j.1476-5381.1974.tb08587.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Pharmacologically active substances formed in egg yolk by cobra venom.

Authors:  W VOGT
Journal:  J Physiol       Date:  1957-04-03       Impact factor: 5.182

2.  Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents.

Authors:  B B Vargaftig; N Dao
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

3.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

4.  Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.

Authors:  B B Vargaftig; P Zirinis
Journal:  Nat New Biol       Date:  1973-07-25

5.  Proceedings: Prostaglandin production by rabbit peritoneal polymorphonuclear leukocytes in vitro.

Authors:  G A Higgs; L J Youlten
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  Prostaglandins released by the spleen.

Authors:  N Gilmore; J R Vane; J H Wyllie
Journal:  Nature       Date:  1968-06-22       Impact factor: 49.962

7.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

8.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

9.  Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  7 in total

Review 1.  Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.

Authors:  B B Vargaftig
Journal:  Agents Actions       Date:  1976-07

2.  Prostaglandin endoperoxides and thromboxanes: formation and effects.

Authors:  S Moncada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977       Impact factor: 3.000

3.  Prostaglandin endoperoxides, serotonin and the superfused rabbit aorta: possible pitfalls in the bio-assay of rabbit aorta contracting substance (RCS).

Authors:  H Bult; I L Bonta
Journal:  Agents Actions       Date:  1976-11

4.  Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.

Authors:  B B Vargaftig; M Chignard
Journal:  Agents Actions       Date:  1975-05

5.  IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

Authors:  A C Zarpelon; T M Cunha; J C Alves-Filho; L G Pinto; S H Ferreira; I B McInnes; D Xu; F Y Liew; F Q Cunha; W A Verri
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 6.  Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses.

Authors:  N Chand; P Eyre
Journal:  Can J Comp Med       Date:  1977-07

7.  Regulation of vascular smooth muscle tone by adipose-derived contracting factor.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.